Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients (OXN3505)

This study has been terminated.
(Lack of recruitment)
Information provided by (Responsible Party):
Mundipharma SAS Identifier:
First received: November 16, 2009
Last updated: September 25, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2013
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)